Pershing Square Capital Management, L.P. and Valeant Pharmaceuticals International, Inc. announced an agreement with Allergan, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com .
↧